critic
cluster
amino
acid
affect
sensit
target
cell
ifninduc
biolog
respons
other
identifi
two
region
expos
surfac
ifn
molecul
associ
receptor
recognit
biolog
potenc
particular
subtyp
determin
level
receptor
recognit
dictat
natur
interact
ifn
subtyp
receptor
complex
ifnar
compos
two
transmembran
subunit
addit
presenc
specif
membran
glycosphingolipid
speci
cell
correl
sensit
associ
membran
contain
glycosphingolipid
facilit
receptormedi
signal
absenc
glycosphingolipid
ifnar
function
enigma
multipl
gene
encod
distinct
speci
exhibit
consider
amino
acid
ident
conserv
given
differ
bind
cell
surfac
receptor
albeit
vari
affin
persist
survivalselect
fittest
gene
ie
gene
encod
highest
affin
receptor
would
presum
ensur
optim
activ
receptor
subsequ
optim
signal
transduct
address
conundrum
examin
promot
region
differ
human
mous
gene
identifi
differ
signatur
pattern
transcript
factor
bind
site
impli
differ
induc
may
differenti
activ
transcript
differ
ifn
recent
initi
studi
direct
examin
virusinduc
ifn
express
profil
respons
virus
tropic
differ
cell
type
vitro
vivo
preliminari
data
suggest
viral
pressur
determin
evolutionari
conserv
multipl
subtyp
specif
differ
ifn
gene
signatur
pattern
induc
differ
virus
origin
cell
type
infect
specif
viru
also
shape
express
profil
unpublish
preliminari
data
suggest
pathogenspecif
activ
discret
signal
effector
determin
ifn
subtyp
induc
activ
tissuecel
origin
defin
spectrum
ifn
subtyp
induc
bind
ifn
subtyp
high
affin
ifnar
result
receptor
activ
signal
cascad
coordin
effect
transcript
translat
regul
target
cell
best
character
signal
cascad
jaksign
transduc
activ
transcript
stat
pathway
review
ref
immedi
follow
ifnifnar
bind
event
receptorassoci
jak
phosphorylatedactiv
phophoryl
key
tyrosin
residu
within
intracellular
domain
receptor
subunit
serv
recruit
site
stat
protein
notabl
recruit
stat
turn
phosphorylatedactiv
jak
includ
stat
famili
member
depend
cell
type
phosphorylatedactiv
stat
form
homdimer
heterodimer
complex
transloc
nucleu
bind
dna
sequenc
within
promot
ifnsensit
gene
isg
fig
activ
heterodim
interact
form
isg
factor
complex
bind
exclus
ifnstimul
respons
element
isr
multipl
stat
homoand
heterodim
independ
recogn
bind
distinct
palindrom
dna
element
gammaactiv
sequenc
ga
fig
isg
either
ga
isr
combin
element
promot
variou
combin
stat
dimer
complex
requir
optim
transcript
activ
specif
isg
inde
natur
specif
stat
protein
express
distinct
cell
type
contribut
cellspecif
ifninduc
gene
express
review
ref
addit
key
residu
dnabind
domain
differ
stat
protein
contribut
specif
cognat
gasbind
partner
induc
activ
distinct
ifn
system
contrast
stat
protein
activ
mani
differ
cytokinereceptor
interact
notabl
activ
critic
induc
respons
bind
isr
wherea
provid
potent
transcript
activ
domain
cogniz
consist
stat
protein
put
dnabind
domain
number
year
ago
other
investig
possibl
addit
ifninduc
complex
may
form
contribut
transcript
activ
inde
ifn
induc
format
heterodim
preferenti
bind
gaslik
sequenc
use
sitedirect
mutagenesi
substitut
isoleucin
residu
two
critic
valin
residu
posit
within
put
dnabind
domain
provid
evid
reduc
chromatin
bind
ifninduc
mutant
heterodim
effect
activ
isr
bind
howev
gasdriven
transcript
activ
reduc
cell
express
dnabind
mutant
reflect
reduc
ifninduc
antivir
growth
inhibitori
respons
data
infer
ifninduc
complex
bind
dna
invok
transcript
activ
subset
isg
continu
studi
identifi
sever
ifninduc
regul
gene
support
function
role
complex
ifninduc
biolog
respons
collect
studi
mani
laboratori
enumer
signal
effector
downstream
activ
ifnar
fig
collabor
studi
dr
leonida
platania
northwestern
univers
school
medicin
chicago
identifi
determin
function
relev
number
discret
signal
pathway
crkl
cellular
homolog
vcrk
protooncogen
serv
adaptor
protein
link
tyrosin
phosphoryl
receptor
downstream
signal
effector
induc
rapid
transient
tyrosin
phosphoryl
crkl
mediat
interact
crkl
interact
via
n
terminu
domain
guanin
exchang
factor
regul
activ
small
g
protein
exhibit
tumor
suppressor
activ
thu
tyrosin
phosphoryl
crkl
link
ifnar
signal
cascad
mediat
growth
inhibitori
respons
interact
constitut
stimul
tyrosinephosphoryl
form
act
dock
site
domain
crkl
crkl
form
complex
transloc
nucleu
ifninduc
complex
bind
vitro
ttctaggaa
palindrom
ga
element
found
promot
subset
isg
thu
activ
ifnar
crkl
function
nuclear
adaptor
protein
associ
regul
gene
transcript
dna
bind
mitogenactiv
protein
kinas
map
serinethreonin
protein
kinas
activ
respons
cellular
stress
proinflammatori
cytokin
growth
factor
mapk
rapidli
phosphoryl
activ
follow
treatment
cell
small
gtpase
activ
type
ifndepend
manner
function
requir
downstream
engag
mapk
pathway
hematopoiet
cell
type
ifn
activ
result
tyrosin
phosphoryl
vav
guanineexchang
factor
follow
vavmedi
gdpgtp
exchang
lead
activ
mapk
nonhematopoiet
cell
activ
map
kinas
kinas
map
kinas
kinas
ifninduc
activ
galligan
et
al
essenti
downstream
phosphoryl
activ
mapk
subsequ
mapk
regul
induct
catalyt
domain
mapkap
mapkap
activ
engag
may
provid
potenti
mechan
gene
transcript
regul
ifnar
activ
relat
implic
regul
histon
phosphoryl
chromatin
remodel
induct
transcript
earli
respons
gene
respons
stress
engag
mapk
pathway
therefor
also
play
critic
role
ifndepend
transcript
regul
interestingli
inhibit
kinas
activ
mapk
block
gene
transcript
without
inhibit
dna
bind
tyrosin
phosphoryl
stat
protein
impli
pathway
act
cooper
stat
pathway
studi
shown
insulinreceptorsubstr
ir
pathway
also
oper
independ
jakstat
pathway
certainli
ifninduc
activ
result
tyrosin
phosphoryl
yet
point
jakstat
ir
pathway
diverg
phosphoryl
ir
protein
provid
dock
site
domain
regulatori
subunit
phosphatidylinositol
kinas
interact
activ
phosphatidylinositol
serin
kinas
activ
catalyt
subunit
subsequ
serinethreonin
protein
kinas
mammalian
target
rapamycin
mtor
activ
turn
mediat
activ
kinas
inactiv
activ
kinas
phosphoryl
ribosom
protein
serin
residu
enabl
mrna
translat
inactiv
repressor
effect
dissoci
eukaryot
translat
initi
factor
eif
therebi
enabl
translat
initi
thu
ifninduc
activ
signal
cascad
serv
complement
jakstat
mediat
transcript
activ
effect
translat
isg
describ
ifndepend
tyrosin
phosphorylatedactiv
stat
transloc
nucleu
regul
gene
transcript
addit
tyrosin
phosphoryl
phosphoryl
serin
essenti
induct
transcript
activ
distinct
serinethreonin
protein
kinas
mtor
protein
kinas
c
pkc
famili
protein
sever
year
ago
provid
evid
activ
engag
ifnar
associ
activ
appear
critic
phosphoryl
serin
inhibit
activ
diminish
serin
phosphoryl
addit
treatment
cell
inhibitor
rottlerin
express
dominantneg
mutant
result
inhibit
gene
transcript
via
isr
ga
element
interestingli
inhibit
also
block
activ
mapk
suggest
dual
mechan
particip
gener
respons
activ
result
activ
multipl
signal
effector
pathway
coordin
invok
gene
protein
regul
target
cell
creat
antivir
respons
activ
jakstat
pathway
critic
control
viral
replic
notabl
ifninduc
activ
mediat
protect
cell
death
brought
encepahlomyocard
viru
emcv
herp
simplex
viru
infect
involv
activ
stat
pathway
addit
mapk
pathway
type
interferon
antivir
contribut
ifninduc
antivir
protect
figur
virusinduc
cell
death
convers
invok
apoptosi
infect
cell
prevent
viral
replic
import
activ
ifnar
subsequ
signal
event
antivir
protect
underscor
viral
challeng
experi
mice
target
disrupt
quit
distinct
direct
antivir
effect
critic
compon
innat
adapt
immun
respons
viral
infect
context
immun
cell
type
ifn
influenc
cell
activ
upregul
cytokin
influenc
cell
respons
enhanc
mhc
class
express
influenc
express
level
chemokin
chemoattract
cell
complement
tcrmediat
signal
ifnarmedi
signal
effector
ir
protein
regul
nk
cell
function
influenc
matur
andor
surviv
dendrit
cell
cell
b
cell
review
ref
studi
mice
reveal
mice
highli
suscept
cardiotrop
coxsacki
viru
infect
suggest
protect
role
type
ifn
pathogenesi
viral
spread
notabl
result
vitro
studi
identifi
exhibit
superior
antivir
activ
compar
although
studi
null
mice
clearli
identifi
import
type
ifn
system
protect
microbi
pathogen
contribut
individu
subtyp
even
vs
address
mous
nonrespons
type
ifn
accordingli
undertaken
studi
address
specif
vivo
function
use
null
mous
gener
former
postdoctor
fellow
group
dr
raj
deonarain
distinguish
role
examin
cours
infect
mice
observ
infect
aggress
compar
mice
express
exacerb
cardiomyopathi
incomplet
ifn
respons
viru
infect
measur
reduc
isg
express
heart
tissu
studi
evid
provid
mice
null
exhibit
increas
suscept
intranas
infect
vaccinia
viru
succumb
infect
dose
subleth
mice
express
data
suggest
failur
invok
virusinduc
transcript
activ
result
blunt
respons
specif
focu
studi
null
mice
immun
cell
develop
activ
mice
exhibit
defect
lymphoid
develop
myelopoiesi
despit
abnorm
proport
balanc
cell
popul
peripher
blood
thymu
spleen
null
mice
activ
lymph
node
splenic
lymphocyt
exhibit
enhanc
cell
prolifer
decreas
product
rel
mice
express
constitut
induc
express
also
reduc
spleen
bone
marrow
macrophag
respect
null
mice
observ
alter
splenic
architectur
null
mice
reduct
resid
macrophag
identifi
potenti
defect
b
cell
matur
null
mice
circul
igm
cell
also
substanti
decreas
null
mice
decreas
number
circul
macrophag
granulocyt
like
reflect
type
interferon
antivir
defect
matur
primit
bone
marrow
hematopoiesi
specif
myelopoiesi
detect
use
experiment
autoimmun
enceph
eae
mous
model
human
multipl
sclerosi
observ
earlier
onset
sever
diseas
null
mice
consist
publish
data
notabl
agreement
find
enhanc
prolif
respons
cell
mice
nonspecif
stimul
observ
memori
cell
peptid
immun
mice
rechalleng
ex
vivo
diseaseinduc
mog
peptid
exhibit
greater
prolif
respons
immun
mice
unpublish
view
altogeth
implic
vitro
vivo
studi
type
ifn
influenc
least
two
facet
antivir
respons
inhibit
viru
infect
directli
ifnaractiv
signal
event
invok
target
inhibit
multipl
stage
replic
cycl
differ
virus
influenc
immun
cell
develop
well
activ
therebi
contribut
shape
immun
respons
involv
viral
clearanc
sever
acut
respiratori
syndrom
sar
emerg
intern
health
crisi
sar
urbani
coronavirus
cov
identifi
etiolog
agent
respons
outbreak
toronto
undertook
clinic
evalu
therapi
sar
patient
ifn
synthet
protein
design
consensu
subtyp
exhibit
superior
bioactiv
vitro
vivo
provid
inform
potenti
therapeut
benefit
toler
ifn
sar
conduct
openlabel
studi
sar
patient
toronto
ifn
treatment
associ
reduc
diseaseassoci
impair
oxygen
satur
rapid
resolut
radiograph
lung
abnorm
lower
level
creatin
kinas
correl
diseas
sever
understand
mechan
action
ifn
limit
sarscov
infect
human
undertaken
seri
vitro
studi
use
murin
hepat
coronaviru
evid
inject
intranas
mice
induc
lung
infect
indistinguish
sarscov
infect
human
levi
et
al
unpublish
specif
aj
mice
highli
suscept
intranas
infect
develop
pulmonari
diseas
character
mark
pulmonari
congest
hyalin
membran
interstiti
thicken
inflamm
alveolar
exud
similar
sar
lung
diseas
human
murin
lung
fibroblast
cell
permiss
infect
treatment
protect
virusinduc
cytopath
effect
dosedepend
manner
use
pharmacolog
inhibitor
specif
target
ifninduc
signal
effector
evid
mapk
play
import
role
activ
lower
dose
pretreat
cell
jak
inhibitor
complet
abrog
protect
effect
activ
earli
postreceptor
activ
event
surpris
abrog
upstream
effector
ifnreceptor
signal
cascad
profound
effect
subsequ
downstream
signal
event
biolog
respons
contrast
higher
dose
inhibit
inhibit
ifninduc
antivir
activ
greater
extent
impli
isg
activ
necessari
ifninduc
activ
furthermor
demonstr
cell
treat
induc
transcript
activ
two
isg
associ
antivir
respons
name
pkr
inhibit
ifninduc
activ
mapk
shown
inhibit
transcript
activ
pkr
abrog
protect
effect
infect
object
virus
infect
target
cell
replic
larg
number
progeni
viru
spread
progeni
initi
new
round
infect
time
virus
evolv
strategi
evad
host
respons
infect
obviou
target
type
ifn
system
mani
virus
encod
form
ifn
antagonist
inde
order
escap
activ
ifn
system
sarscov
appear
block
step
earli
nuclear
transport
transcript
factor
essenti
promot
activ
chemokin
receptor
critic
clearanc
infecti
pathogen
specif
chemokin
implic
direct
lymphocyt
traffick
site
infect
activ
effector
function
immun
cell
elimin
infecti
pathogen
chemokin
exert
activ
engag
specif
seventransmembran
g
proteincoupl
receptor
virus
turn
evolv
variou
defenc
chemokin
defenc
rang
product
antagonist
either
chemokin
chemokin
receptor
coopt
chemokin
receptor
viral
entri
recent
year
laboratori
becom
interest
poxvirus
specif
myxoma
viru
vaccinia
viru
vacv
hijack
chemokin
receptor
invok
permiss
environ
viral
replic
myxoma
vacv
member
chordopoxvirina
subfamili
poxvirida
famili
review
ref
comprehens
analysi
poxviru
genom
sequenc
identifi
number
viru
encod
immunomodulatori
gene
includ
solubl
cytokin
bind
protein
serpin
chemokin
bind
protein
complement
control
protein
member
semaphorin
receptor
famili
review
ref
becom
appar
chemokin
receptor
play
critic
role
transmiss
pathogenesi
specif
viral
infect
tion
addit
provid
evid
myxoma
virusinduc
stat
ir
activ
fig
notabl
activ
result
rapid
tyrosin
phosphorylationactiv
phosphorylationactiv
format
dimer
exhibit
dnabind
activ
phosphoryl
associ
phosphoryl
fig
jak
phosphoryl
insensit
pertussi
toxin
inhibit
target
g
protein
signal
indic
mediat
tyrosin
phosphoryl
event
coupl
directli
g
protein
mediat
signal
event
wherea
activ
effect
hiv
env
protein
inhibit
pertussi
toxin
myxoma
virusinduc
phosphoryl
event
stimul
signal
event
affect
pertussi
toxin
treatment
given
myxoma
viru
infect
express
cell
block
herbamycin
inhibitor
tyrophostin
viral
infect
may
depend
nong
proteincoupl
signal
transduct
pathway
trigger
infect
myxoma
viru
particl
extend
studi
examin
vacv
activ
myxoma
viru
exact
mechan
vv
bind
entri
cell
known
importantli
myxoma
viru
vacv
enter
permiss
restrict
cell
yet
postentri
event
determin
permiss
viral
replic
evid
vacvinduc
phosphorylationactiv
signal
effector
permiss
cell
express
knockdown
express
abrog
viral
replic
signal
event
myxoma
viru
vacv
infect
block
herbimycin
tyrophostin
pertussi
toxin
indic
vacv
infect
also
depend
tyrosin
phosphoryl
g
proteincoupl
signal
event
data
highlight
interest
inconsist
ifninduc
activ
jakstat
pathway
confer
protect
phenotyp
viru
infect
myxoma
vacvinduc
activ
pathway
albeit
mediat
differ
receptor
lead
permiss
environ
viral
infect
appar
contradict
confound
one
consid
activ
ifn
respons
determin
restrict
environ
poxviru
infect
poxvirus
encod
ifn
antagonist
specif
disrupt
ifn
respons
ongo
studi
investig
downstream
target
signal
pathway
poxvirusinfect
cell
discern
addit
signal
effector
network
distinguish
eventu
biolog
responsevir
replic
inhibit
review
highlight
multifacet
approach
understand
cell
surfac
receptor
activ
result
network
signal
transduct
pathway
converg
invok
specif
biolog
outcom
ifnifnar
interact
antivir
respons
becom
clear
viral
pressur
influenc
evolutionari
preserv
multipl
subtyp
ongo
ifn
evas
strategi
virus
includ
command
aspect
ifninduc
signal
network
activ
distinct
cell
surfac
receptor
viral
advantag
futur
object
direct
understand
signal
pathway
effector
determin
equilibrium
restrict
environ
viral
replic
permiss
one
type
interferon
antivir
